| Title | Date | PubMed ID |
|---|
| Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D. | 2012 Apr | 22129033 |
| New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships. | 2012 Jan 15 | 22204908 |
| The native conformation of plasmepsin II is kinetically trapped at neutral pH. | 2011 Sep 15 | 21767524 |
| Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents. | 2010 May 27 | 20438064 |
| Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum. | 2010 Mar | 19946719 |
| Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein. | 2010 Mar 1 | 20112327 |
| Investigating alternative acidic proteases for H/D exchange coupled to mass spectrometry: plasmepsin 2 but not plasmepsin 4 is active under quenching conditions. | 2010 Jan | 19906540 |
| Functional chimera of porcine pepsin prosegment and Plasmodium falciparum plasmepsin II. | 2010 Jan | 19910416 |
| Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. | 2009 Dec | 19752273 |
| New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates. | 2009 Oct 7 | 19763297 |